about
Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets.Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed plateletsDendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.The CD47 pathway is deregulated in human immune thrombocytopenia.Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.Human megakaryocyte biology and pathophysiology.Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signalingRisk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric studyReinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial.Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and SplenomegalyThe CD4 receptor plays essential but distinct roles in HIV-1 infection and induction of apoptosis in primary bone marrow GPIIb/IIIa+ megakaryocytes and the HEL cell line.Decreased Pasteur effect in platelets of aged individuals.Molecular and functional characterization of CD133(+) stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells.Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia.A novel model of CCl4-induced cirrhosis with ascites in the mouse.Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphisms.Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis.Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience.JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis.Comparison of JAK2(V617F) -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.MYH9-related thrombocytopenia and intracranial bleedings: a complex clinical/surgical management and review of the literature.Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling.Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34 CellsLow-dose methotrexate as treatment of myeloproliferative neoplasms: Proof of principle of clinical activityCirculating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopeniaRuxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallengePlatelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosisImpact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective studyStem cell mobilization and collection in patients with liver cirrhosisEffects of granulocyte colony stimulating-factor in a rat model of acute liver injuryGene expression profiling of normal and malignant CD34-derived megakaryocytic cells
P50
Q33331257-241E956A-CF1B-4F8B-998A-25A8A3A56C5CQ33342580-F2AC27AE-B60E-4546-A1A7-8E4D32345C72Q33371694-C2FAD220-AA61-4CEE-B5BD-6944CCD7A6C6Q33393546-6ADE66CD-2AB5-44B8-9F9D-1E2B94C49A83Q33403052-B296D708-397E-4DF9-9804-092ADA912E8CQ33416947-C471194C-C325-46CE-93CE-4DACF696F3CAQ33429426-D6426ECC-313E-44ED-A7C2-D4AA7909F637Q33496946-EE31D992-69D8-42AB-93CB-43B006C2F7EEQ36045296-763C185B-8253-4F43-9C64-18396673BEDAQ37709259-65437CAE-7DCA-4F05-9456-A59CC68E3985Q38814941-BB257859-B30C-49D7-92E6-A6C0253067F6Q38830536-ECBFBB6C-2527-42AF-8E1E-0D32DF2D3964Q40477293-435DA267-845C-4CE6-BBAF-FBC2E419A3EAQ40564541-5B7F9E87-AF15-46B5-8A58-A36BF48EDB34Q41287953-257DD920-FA53-455F-BDC8-D48887C993D4Q42503862-AF5B882A-21C0-4E5A-8334-03F12F30A5D1Q42515221-4C58798C-90B3-471F-BB03-B371FBEFBC57Q42708663-1332F369-1CB3-42F2-8E8F-B41A6AAF7FDAQ43255690-22D440F3-7A45-4007-A513-ED3AF1961738Q44217288-5542766A-D3D6-44AA-8B5F-60D9B79FEC92Q45236578-8B862387-B717-470E-B287-50C7FCF217C4Q45912397-76D63E20-1B95-4EBE-88DB-283862D7604BQ46113435-072CA4D8-2A98-4634-AAAA-760D7D36E0CFQ46126059-C4555F03-325A-4C36-B5A6-EBA2DF5BD6A5Q47418268-EF304795-39FB-4A16-A5C6-EC55DCE1BBBBQ48138032-2A832D2D-9F59-468A-8E5B-ECA955768739Q50352928-F5A2D03A-8EB8-44A2-B786-A07856863981Q52721155-8ED91E6B-E2CA-416F-B1FD-E1C3E5E6E691Q53407049-B4BF7ADE-1FBA-4BAE-BDD1-C01108FBB1D5Q54282700-9BA329D2-AC17-45B6-BA7F-932F6D43C15BQ54585988-B423CFEE-FBB2-4041-9303-D77F4D557986Q56373501-9ABCA619-B423-4577-B4A0-9CEF3B97BBDBQ56964037-792CD657-6057-42BA-A36C-71EE747C6CC9Q56969429-A24EA63B-2697-478F-9AC4-81420869F4EFQ56970836-8024632B-94E8-482F-8744-2B78D96C2A8FQ56971079-332142DB-9469-41FC-9883-AF83D90B8C1AQ56984881-E9457DF3-408D-4E29-B5AF-A6FDA322EE8CQ56992979-98BFB780-F582-4F2C-9810-BC50F092DFA5Q56994380-18B34003-7466-489E-9028-DDD8793EF398Q57001073-17B7C4A5-FD31-4A34-B852-1C3099C18CF0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lucia Catani
@ast
Lucia Catani
@en
Lucia Catani
@es
Lucia Catani
@nl
Lucia Catani
@sl
type
label
Lucia Catani
@ast
Lucia Catani
@en
Lucia Catani
@es
Lucia Catani
@nl
Lucia Catani
@sl
prefLabel
Lucia Catani
@ast
Lucia Catani
@en
Lucia Catani
@es
Lucia Catani
@nl
Lucia Catani
@sl
P106
P1153
7004970532
P21
P31
P496
0000-0002-4650-201X